This Pharma Stock Is Surging 40%. Neurocrine Is Buying It in $2.9 Billion Deal.

Apr 6, 2026 - 13:00

0

This Pharma Stock Is Surging 40%. Neurocrine Is Buying It in $2.9 Billion Deal.

Related Posts

JPMorgan rebrands diversity program

JPMorgan rebrands diversity program

Mar 21, 2025 9

The five keys to unlock homeownership for emerging buyers

The five keys to unlock homeownership for emerging buyers

Mar 21, 2025 1

Elon Musk reassures Tesla workers with all-hands meeting, admits it 'feels like Armageddon'

Elon Musk reassures Tesla workers with all-hands meetin...

Mar 21, 2025 7

Factbox-What fighter jet programs does the US Air Force have?

Factbox-What fighter jet programs does the US Air Force...

Mar 21, 2025 3

Coty Divests Stake in SKKN by Kim

Coty Divests Stake in SKKN by Kim

Mar 21, 2025 0

Disney investor pledges to continue fight as shareholders reject proposal to distance company from LGBT group

Disney investor pledges to continue fight as shareholde...

Mar 21, 2025 5